Showing results (231-240 of 393) with videos related to
Sort By:
Pageof 40
Clinical Cardiology|September 1, 2021
Atrial structure and function in middle-aged, physically-active males and females: A cardiac magnetic resonance studyMeghan Glibbery, Laura Banks, Mustafa A Altaha, et al.Resuscitation|May 1, 2019
Health care utilization prior to out-of-hospital cardiac arrest: A population-based studyMony Shuvy, Maria Koh, Feng Qiu, et al.Journal of Clinical Medicine|July 9, 2022
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-AnalysisBenjamin J R Buckley, Deirdre A Lane, Peter Calvert, et al.Implementation Science : IS|January 18, 2011
A knowledge translation collaborative to improve the use of therapeutic hypothermia in post-cardiac arrest patients: protocol for a stepped wedge randomized trialKatie N Dainty, Damon C Scales, Steve C Brooks, et al.The Canadian Journal of Cardiology|April 28, 2006
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scalePaul Dorian, Suzan S Cvitkovic, Charles R Kerr, et al.NMR in Biomedicine|August 14, 2015
Characterization of the ultrashort-TE (UTE) MR collagen signalAdrienne G Siu, Andrew Ramadeen, Xudong Hu, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 14, 2020
Association of Left Ventricular Ejection Fraction with Mortality and HospitalizationsPaul Angaran, Paul Dorian, Andrew C T Ha, et al.The American Journal of Cardiology|February 27, 2010
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillationJean-Yves Le Heuzey, Günter Breithardt, John Camm, et al.Journal of Cardiovascular Electrophysiology|February 11, 2026
Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 StudyPaul Dorian, Marco Alings, Benoit Coutu, et al.Nature Medicine|December 13, 2023
Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trialAnders G Holst, János Tomcsányi, Birgitte Vestbjerg, et al.Pageof 40